Bimatoprost as a Treatment for Graves' Orbitopathy

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05532072` - Rapamycin Plus Methylprednisolone Versus Methylprednisolone Alone in Active, Moderate-to-severe Graves' Orbitopathy.	Early Phase 1
Completed	`NCT01727973` - Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy	Phase 1/Phase 2
Recruiting	`NCT06112340` - A Phase 2b Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)	Phase 2/Phase 3
Recruiting	`NCT05678374` - Exploring Immunological Markers Associated With Mental Fatigue in Graves' Disease
Not yet recruiting	`NCT06413043` - Study on Efficacy of Add on Selenium in Mild-to-moderate Graves Ophthalmopathy	N/A
Withdrawn	`NCT01379196` - Use of Azithromycin as Immunomodulatory Therapy in Grave&Apos;s Orbitopathy	Phase 1/Phase 2
Recruiting	`NCT06275373` - The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction
Recruiting	`NCT06226545` - A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease	Phase 2
Recruiting	`NCT05126147` - Hydroxychloroquine in Mild Graves' Orbitopathy	Phase 4
Recruiting	`NCT01999790` - Comparison Study Between Two Techniques for Correction of Upper Lid Retraction in Patients With Grave's Orbitopathy	N/A
Recruiting	`NCT03066076` - Total Thyroidectomy Versus Thionamides in Patients With Moderate-to-Severe Graves' Ophthalmopathy	Phase 3
Active, not recruiting	`NCT03122847` - Glucocorticoids and Bone in Graves' Ophthalmopathy
Terminated	`NCT01893450` - Bromocriptine and Pentoxifylline in Ophthalmopathy Autoimmune Treatment	N/A
Completed	`NCT00348413` - Thyroid Treatment Trial	N/A
Completed	`NCT03498417` - Anti-insulin-like Growth Factor-1 Receptor (IGF-1R) Antibodies in Graves' Disease and Graves' Orbitopathy
Not yet recruiting	`NCT04598815` - Sirolimus for Graves' Orbitopathy (GO)	Phase 2
Terminated	`NCT01114503` - A Safety and Tolerability Study of Otelixizumab in Thyroid Eye Disease	Phase 2
Completed	`NCT05793359` - Comparison of the Effectiveness of Two Glucocorticoid Regimens for Treatment of Graves' Orbitopathy
Completed	`NCT05775185` - Therapeutic Efficacy of Orbital Radiotherapy in Patients With Graves' Orbitopathy
Recruiting	`NCT02203682` - Doxycycline Treatment in Mild Thyroid-Associated Ophthalmopathy	Phase 2

NCT number	NCT03708627
Study type	Interventional
Source	Johns Hopkins University
Contact	Emily Li, MD
Phone	410-955-1112
Email	eli20@jhmi.edu
Status	Recruiting
Phase	Early Phase 1
Start date	November 1, 2017
Completion date	July 1, 2027

Bimatoprost as a Treatment for Graves' Orbitopathy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms